Effects of Mirtazapine on Appetite in Advanced Cancer Patients

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 8, 2007

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Advanced CancerAnorexiaWeight LossInsomnia

Interventions

DRUG

Mirtazapine

15 mg by mouth (PO) daily x 15 days; Day 22-29, increased to 30 mg PO daily.

DRUG

Placebo

One placebo tablet by mouth daily.

Trial Locations (1)

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER